Arcturus Therapeutics Holdings

Arcturus Therapeutics Holdings

ARCT· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock -63.9% in FY2025

Joseph E. Payne is the CEO of Arcturus Therapeutics Holdings and was paid $1.7M in FY2025 (Dec), down 54%.

Pay$100 in the stock at the end of FY20 → $14
CEO pay is from each Arcturus Therapeutics Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives5

See all
  1. 1Joseph E. PayneFY2025
  2. 2Andy SassineFY2025
  3. 3Dr. Padmanabh ChivukulaFY2025
  4. 4Lance KurataFY2025
  5. 5Joe RobertsFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Arcturus Therapeutics Holdings paid its 5 named executives $4.8M in total in FY2025 (Dec). CEO Joseph E. Payne was paid $1.7M of that.

Name
Joseph E. PaynePresident and Chief Executive Officer, Director
Andy SassineFormer Chief Financial Officer
Dr. Padmanabh ChivukulaChief Scientific Officer, Chief Operating Officer
Lance KurataChief Legal Officer
Joe RobertsInterim Principal Financial Officer and Accounting Officer; Controller

of each named executive, from the Summary Compensation Table of each proxy.

Peers15

See all

The FY2025 (Dec) proxy of Arcturus Therapeutics Holdings names 15 peer companies for pay. Pay versus performance data of Arcturus Therapeutics Holdings for that year is not on file, so it has no rank.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board4

See all
  • James BarlowDirector · 7 yr on the boardIndependentAudit (Chair), Compensation—Paid as an executive
  • Magda MarquetDirector · 7 yr on the boardIndependentCompensation (Chair)—Paid as an executive
  • Edward W. HolmesDirector · 6 yr on the boardIndependentAudit, Nominating and Corporate Governance (Chair)—Paid as an executive
  • Jing L. MarantzDirector · 4 yr on the boardIndependentCompensation, Nominating and Corporate Governance—Paid as an executive

The board of the latest proxy (FY2025).

Activity

  1. Pay
    Arcturus Therapeutics Holdings COO pay fell 46% to $862.0K. The stock fell 64% in FY2025 (Dec).
    DEF 14A
  2. Pay
    Arcturus Therapeutics Holdings General counsel pay fell 44% to $830.0K. The stock fell 64% in FY2025 (Dec).
    DEF 14A
  3. Pay
    Arcturus Therapeutics Holdings CFO pay fell 33% to $273.6K. The stock fell 64% in FY2025 (Dec).
    DEF 14A
  4. Pay
    Arcturus Therapeutics Holdings CFO pay rose 17% to $405.7K. The stock fell 46% in FY2024 (Dec).
    DEF 14A
  5. Pay
    Arcturus Therapeutics Holdings CEO pay fell 54% to $1.7M. The stock fell 64% in FY2025 (Dec).
    DEF 14A
  6. Pay
    Arcturus Therapeutics Holdings Former CFO pay fell 27% to $1.2M. The stock fell 64% in FY2025 (Dec).
    DEF 14A
  7. Pay
    Arcturus Therapeutics Holdings COO pay fell 50% to $1.6M. The stock fell 46% in FY2024 (Dec).
    DEF 14A
  8. Pay
    Arcturus Therapeutics Holdings COO pay rose 314% to $3.1M. The stock fell 54% in FY2022 (Dec).
    DEF 14A
  9. Pay
    Arcturus Therapeutics Holdings General counsel pay fell 29% to $1.5M. The stock fell 46% in FY2024 (Dec).
    DEF 14A
  10. Pay
    Arcturus Therapeutics Holdings General counsel pay rose 111% to $1.2M. The stock fell 54% in FY2022 (Dec).
    DEF 14A
  11. Pay
    Arcturus Therapeutics Holdings CEO pay fell 24% to $3.7M. The stock fell 46% in FY2024 (Dec).
    DEF 14A
  12. Pay
    Arcturus Therapeutics Holdings CEO pay rose 483% to $5.6M. The stock fell 54% in FY2022 (Dec).
    DEF 14A
  13. Pay
    Arcturus Therapeutics Holdings Former CFO pay fell 26% to $1.6M. The stock fell 46% in FY2024 (Dec).
    DEF 14A
  14. Pay
    Arcturus Therapeutics Holdings Former CFO pay rose 319% to $3.1M. The stock fell 54% in FY2022 (Dec).
    DEF 14A
  15. Pay
    Arcturus Therapeutics Holdings General counsel pay rose 77% to $2.1M. The stock rose 86% in FY2023 (Dec).
    DEF 14A
  16. Pay
    Arcturus Therapeutics Holdings CEO pay fell 13% to $4.9M. The stock rose 86% in FY2023 (Dec).
    DEF 14A
  17. Pay
    Arcturus Therapeutics Holdings Former CFO pay fell 31% to $2.2M. The stock rose 86% in FY2023 (Dec).
    DEF 14A

Filings6

See all
Proxy statementDEF 14AApr 24, 2026FY2025
Annual report10-KMar 3, 2026FY2025
Proxy statementDEF 14AApr 25, 2025FY2024
Annual report10-KMar 6, 2025FY2024
Proxy statementDEF 14AApr 29, 2024FY2023
Annual report10-KMar 14, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data